LMP1 activates NF-κB via degradation of IκBα in nasopharyngeal carcinoma cells

Chinese Medical Journal

Volumn 114, Issue 7, 2001, Pages 718-722

  Yin, Liqun ^a   Liao, Wei ^a   Deng, Xiyun ^a   Tang, Min ^a   Gu, Huanhua ^a   Li, Xiaoyan ^a   Yi, Wei ^a   Cao, Ya ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Epstein barr virus; I B ; Latent membrane protein; Nasopharyngeal carcinoma; NF B

Indexed keywords

DNA BINDING PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ARTICLE; CELL CULTURE; HUMAN; METABOLISM; NASOPHARYNX TUMOR; PHOSPHORYLATION; PHYSIOLOGY; TRANSACTIVATION; TRANSPORT AT THE CELLULAR LEVEL; VIROLOGY;

BIOLOGICAL TRANSPORT; DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; PHOSPHORYLATION; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 0035411876     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Moorthy RK, Thorley-Lawson DA. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP1-are required for transformation of Rat-1 fibroblasts. J Virol 1993;67: 1638-1648.
2. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115.
3. Floettmann JE, Ward K, Rickinson AB, et al. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 1996; 223:29-40.
4. Verma IM, Stevenson JK, Schwarz EM, et al. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 1995;9:2723-2735.
5. Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-681.
6. Guttridge DC, Albanese C, Reuther JY, et al. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cel Biol 1999;19:5785-5799.
7. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 1999;18:6910-6924.
8. Liao W, Tang M, Li JJ, et al. Epstein-Barr virus encoded latent membrane protein 1 increases expression of immunoglobulin K light chain through NF-κB in a nasopharyngeal carcinoma cell line. Acta Biochim Biophys Sin 1999;31:659-663.
9. Zhang Q, Sun N, Chen X, et al. Effects of EB virus LMP on the differentiation and growth of human nasopharyngeal carcinoma cell line CNE1. Chin J Pathol 1999;28:285-289.
10. Zhu HC, Yao KT, Li GY, et al. The establishment and biological characteristics of four nasopharyngeal carcinoma cell lines. Bull Hunan Med Univ 1992;17:103-107.
11. Liao W, Yi H, Li XY, et al. Doxycycline dependent expression of Epstein-Barr virus latent membrane protein 1 with Tet regulating system in nasopharygeal carcinoma cell line. Acta Biochim Biophy Sin 1999;31:309-312.
12. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual 2nd ed. Cold Spring: Harbor Laboratory Press 1989:870-877.
13. Kaltschmidt B, Uherek M, Volk B, et al. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci 1997;94:2642.
14. Wang CY, Cusack JC, Liu R, et al. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nature Med 1999;5:412-417.
15. Batra RK, Guttridge DC, Brenner DA, et al. IκBα gene transfer is cytotoxic to squamous cell lung cancer cells and sensitizes them to TNFα-mediated cell death. Am J Respir Cell Mol Biol 1999;21:238-245.